Galectin Therapeutics Issues Statement Regarding GALTW and GALTU
23 mars 2017 08h30 HE
|
Galectin Therapeutics
NORCROSS, Ga., March 23, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced today that trading will be...